|
Researchers at Scholl College's Center for Lower Extremity Ambulatory Research (CLEAR) at Rosalind Franklin University of Medicine and Science, Leiden University in the Netherlands, and Texas A&M University have presented important new information that c |
|
Millions of Americans take medications for hypertension but do not achieve control of their blood pressure. Single-tablet combinations of drugs may be what it takes to get blood pressure under control, even in people with moderate hypertension, according |
|
ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation), a landmark, six-year trial has now closed the part of the study that aims to investigate the effect of Preterax, a blood pressure lowering agent containin |
|
To help encourage Americans to take more steps towards healthier lifestyle behaviors, the American Diabetes Association (ADA) and PCE Health & Fitness joined together to develop a unique contest to emphasize the importance of regular physical activity in |
|
Today the New England Journal of Medicine published an article entitled, "Effect of
Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes."
The conclusions of this analysis of previous studies of rosiglitazone (brand |
|
The Juvenile Diabetes Research Foundation, the world's largest charitable funder of type 1 diabetes research, will host the Global Diabetes Research Forum (GDRF) in St. Louis on June 1, 2007 as part of its annual conference. Leaders from the scientific, |
|
Spending money to improve diabetes care at federally qualified community health centers is a sound investment, according to one of the first studies to examine the clinical and economic impact of quality improvement on diabetes care.
|
